Long-Term Effectiveness and Persistence of Using Ustekinumab vs TNF Inhibitors in Patients With Psoriatic Arthritis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Long-term effectiveness and persistence of ustekinumab and TNF inhibitors in patients with psoriatic arthritis: final 3-year results from the PsABio real-world study
Ann. Rheum. Dis 2022 Dec 13;[EPub Ahead of Print], L Gossec, S Siebert, P Bergmans, K de Vlam, E Gremese, B Joven-Ibáñez, TV Korotaeva, F Lavie, W Noël, MT Nurmohamed, PP Sfikakis, M Sharaf, E Theander, JS SmolenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.